Ignite your Proteomics Research with SPARC BioCentre

January 17, 2019

Located on the top floor of the Peter Gilgan Centre for Research and Learning, SPARC BioCentre is a world-class facility operated by The Hospital for Sick Children. SPARC has been in continuous operation for over 27 years (albeit under different names), yet remains state-of-the-art thanks to strategic investments by SickKids and the Canada Foundation for…

Read More

Genomics at the Tipping Point – Partnering to Accelerate Market Uptake & Impact

December 13, 2018

On December 5th, 2018, Ontario Genomics hosted Genomics at the Tipping Point: Partnering to Accelerate Market Uptake & Impact, a captivating symposium focused on closing the gap between genomics innovations and market impact. A packed auditorium heard from innovators using genomics to advance the mining, agriculture and agri-food, bioengineering, natural resources and health sectors.  In…

Read More

Genomics increase local brewers’ profitability & support growth of Ontario suppliers

December 12, 2018

The total economic impact of small breweries in Ontario is estimated to be approximately $1.4 Billion (2017) and the sector continues to grow according to the Ontario Craft Brewers Association. Some yeasts, which are a key ingredient in craft beer, slow fermentation which can result in losses for brewers. Escarpment Laboratories, a Guelph-based yeast supplier for…

Read More

Drug Discovery at SPARC: Enabling high-throughput biology and discovery

December 12, 2018

The SPARC Drug Discovery (DD) facility is the product of a strategic initiative made by SickKids to provide researchers access to state-of-the-art infrastructure and world-class expertise to develop robust and predictive assays to identify small molecule modulators of biochemical targets and/or cellular phenotypes relevant to human disease. To this end, over the past decade, SPARC-DD…

Read More

Canada SynBio 2019 – Pitch Competition

December 7, 2018

Accelerating Start-ups by Design Canada SynBio 2019 Pitch Competition Program Overview Are you a Canadian-based startup company working to commercialize a synbio-based product or service? We want you to apply to pitch for up to $25,000 in prize money in front of leading investors! Prizes Startup companies will be competing for a first prize of $25,000…

Read More

Welcome Filippo Miglior and Nezar Rghei!

December 4, 2018

It is with great pleasure that we welcome Filippo Miglior and Nezar Rghei to the Ontario Genomics team. Nezar joined us on December 3rd as Vice President Strategic Partnerships & Resource Development, and Filippo will join us on January 7th as Chief Scientific Officer and Vice President, Sector Innovation and Programs. We live in the most interesting of times, where scientific…

Read More

Ontario Genomics welcomes two new board members and appoints Interim Chair

November 7, 2018

Ontario Genomics is pleased to announce the appointment of Dr. Tom Corr and Dr. Diane Gosselin to its Board. These highly accomplished individuals bring a wealth of insight, experience and expertise in areas crucial to our business that will contribute to fulfilling the mission and achieving the strategic objectives of Ontario Genomics. Tom Corr is President…

Read More

The Genetic and Molecular Epidemiology Laboratory (GMEL) – Advancing the promise of personalized medicine

November 7, 2018

The Genetic and Molecular Epidemiology Laboratory (GMEL) at McMaster University is a premier genomics and proteomics facility offering a broad range of analytical services for academic and industry scientists. Established in 2009 by Guillaume Paré, MD, GMEL offers a broad array of cutting-edge “omics” platforms and technologies for high-throughput analyses of nucleic acids and protein…

Read More

Revealing the molecular mystery of human liver cells

November 7, 2018

A map of the cells in the human liver has been created by University Health Network Transplant Program and University of Toronto researchers, revealing for the first time differences between individual cells at the molecular level which can have a profound impact on their behaviour in tissue, tumours and disease.

Read More

StemCore Laboratories: Catalyzing genomics projects in the Nation’s Capital

October 4, 2018

StemCore Laboratories is one of Canada’s most advanced genomics facilities, fueling breakthroughs in stem cell research and regenerative medicine, as well as other health-related areas such as cancer, heart disease, and diabetes. Located at the General Campus of the Ottawa Hospital, StemCore is a core facility of the Ottawa Hospital Research Institute (OHRI) and the…

Read More